Our Company
Dextra was founded in 1989 to provide carbohydrate synthesis and analytical services to the scientific research community
Providing world leading, innovative solutions for the total synthesis of challenging complex carbohydrates, Dextra typically simplify routes and reduce the number of synthetic steps required to achieve the target compound. From a few milligrams to multi kilogram scale our chemists offer unparalleled expertise in oligosaccharide and chiral chemistry taking your project from discovery to clinical trial.
Our catalogue showcases a comprehensive range of carbohydrate products, exploiting the complexity and diversity of glycobiology. Products include neoglycoproteins, neoglycolipids, heparin derivatives, iminosugars, blood group products, oligosaccharides, glycans, building blocks and a range of rare sugars for glycobiology and reference standards.
Laboratories in Reading, UK
Our Approach
We offer a comprehensive custom synthesis service to take your project from discovery to clinical trial
Our core competencies include complex oligosaccharide chemistry, route design, process development, optimisation and scale-up, process validation, technology transfer and GMP manufacture for Phase 1 and Phase 2 clinical trials.
Our fully equipped analytical laboratories offer expert support with a comprehensive range of analytical techniques available. All activities are fully supported by a strong Quality Management System and Health & Safety Framework and we have successfully achieved ISO9001:2015 registration.
Our Core Competencies
At the heart of everything we do
-
Expertise
Our expert team specialise in the synthesis of carbohydrate molecules and related substances.
-
Innovation
Providing creative solutions to challenging problems.
-
Responsiveness
We prioritise meeting our customer’s timetable and expectations.
-
Reliability
We overcome problems to produce a consistent product and service to our customers.
-
Project management
Efficient delivery of your project to your specifications.
-
Route design
We design synthetic routes and evaluate their viability with the longer term goals of an efficient, sustainable and robust process in mind.
-
Multi-step synthesis
We have a wealth of experience in the synthesis of complex targets, frequently reducing the number of synthetic steps after scouting out alternative routes.
-
Process development
Dextra has a proven record of developing innovative solutions, to minimise costs, reduce technology transfer issues and generate optimised robust routes.
-
Quality
Consistant delivery of high quality GMP and non-GMP products.
Our Business
Proud to be part of ICE Pharma
Dextra is an important part of ICE Pharma who are leaders in the field of bile acid products and for pharmaceutical use.
Founded more than 60 years ago, ICE Pharma is now one of the main global players in bile-related products, with a network of specialist facilities and subsidiaries in Europe, Asia, Oceania, North and South America.
Thanks to the long experience of Dextra, the group can now boast leading expertise and comprehensive service in the synthesis, analysis and manufacture of carbohydrates.
